Cara Therapeutics Inc
CARA
Market Cap$8.11M
Close$
$0.13
97.6% downside
Current Fair Value
97.6% downsideOvervalued by 97.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $8.11 Million |
|---|---|
| Enterprise Value | $-29,792,447.00 |
| Dividend Yield | $0 (-%) |
| Earnings per Share | $-1.55 |
| Beta | 0.41 |
| Outstanding Shares | 54,843,841 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | - |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | -5.32 |
| Enterprise Value to Revenue | -3.43 |
| Enterprise Value to EBIT | 0.39 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Cara Therapeutics Inc
CEO: Derek Chalmers